← FDA Drug Approvals (Drugs@FDA)

TANDEARIL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1960-12-21

Drug application

FDA Application #

NDA012542

Application type

New Drug Application

Brand name

TANDEARIL

Generic name

Oxyphenbutazone

Active ingredients

OXYPHENBUTAZONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1960-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown